Astera Labs, Inc. (ALAB) – What Are Brokerages Thinking About This Stock?

Shares of Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) have received an average rating of “Moderate Buy” from the twenty-one ratings firms that are currently covering the firm, MarketBeat reports. Nine analysts have rated the stock with a hold recommendation and twelve have assigned a buy recommendation to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $325.89.

Several research analysts recently weighed in on the company. Wall Street Zen raised Astera Labs from a “hold” rating to a “buy” rating in a research report on Saturday, November 7th. Susquehanna lowered their price target on Astera Labs from $310.00 to $258.00 and set a “neutral” rating for the company in a research report on Wednesday, November 4th. Zacks Research downgraded Astera Labs from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 5th. Northland Securities upgraded Astera Labs from a “market perform” rating to an “outperform” rating and set a $315.00 price target for the company in a research note on Wednesday, November 4th. Finally, Royal Bank Of Canada dropped their target price on shares of Astera Labs from $500.00 to $400.00 and set an “outperform” rating for the company in a research report on Wednesday, November 4th.

View Our Latest Analysis on ALAB

Insider Activity

In related news, Director Manuel Alba sold 183,000 shares of the company’s stock in a transaction on Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total transaction of $51,263,790.00. Following the completion of the sale, the director directly owned 253,863 shares of the company’s stock, valued at approximately $71,114,642.19. This represents a 41.89% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan Dyckerhoff sold 8,994 shares of the firm’s stock in a transaction dated Thursday, November 5th. The shares were sold at an average price of $211.41, for a total value of $1,901,421.54. Following the completion of the transaction, the director directly owned 1,987 shares in the company, valued at $420,071.67. This trade represents a 81.91% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 417,090 shares of company stock worth $102,663,347 in the last quarter. Insiders own 10.40% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in ALAB. BlackRock Inc. acquired a new position in Astera Labs in the 2nd quarter worth $6,609,581,000. ABS Investment Management LLC purchased a new position in Astera Labs in the 2nd quarter valued at about $1,980,382,000. Van ECK Associates Corp grew its stake in shares of Astera Labs by 20.0% during the second quarter. Van ECK Associates Corp now owns 2,237,961 shares of the company’s stock valued at $1,080,980,000 after acquiring an additional 373,545 shares in the last quarter. Bank of America Corp DE acquired a new stake in shares of Astera Labs during the second quarter valued at about $1,061,791,000. Finally, Atreides Management LP grew its stake in shares of Astera Labs by 102.1% during the third quarter. Atreides Management LP now owns 2,459,106 shares of the company’s stock valued at $875,368,000 after acquiring an additional 1,242,311 shares in the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Astera Labs Stock Performance

ALAB opened at $179.58 on Friday. Astera Labs has a 1 year low of $97.89 and a 1 year high of $499.48. The company’s 50 day simple moving average is $285.19 and its 200 day simple moving average is $258.24. The stock has a market capitalization of $31.39 billion, a PE ratio of 71.55 and a beta of 3.85.

Astera Labs (NASDAQ:ALAB – Get Free Report) last announced its quarterly earnings results on Tuesday, November 3rd. The company reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.19 by $0.13. Astera Labs had a net margin of 29.64% and a return on equity of 25.35%. The company had revenue of $584.90 million for the quarter, compared to analyst estimates of $550.78 million. During the same quarter last year, the business earned $0.49 EPS. Astera Labs’s revenue for the quarter was up 153.6% on a year-over-year basis. As a group, sell-side analysts expect that Astera Labs will post 2.99 earnings per share for the current fiscal year.

About Astera Labs

(Get Free Report)

Astera Labs, Inc. is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems. The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.

Further Reading

Analyst Recommendations for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.